Investigating the Reasons for Receiving the Second Booster Dose of the COVID-19 Vaccine in Adults and in People with Chronic Medical Conditions in Southern Italy DOI Creative Commons
Grazia Miraglia del Giudice, Lucio Folcarelli, Giorgia Della Polla

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(4), P. 737 - 737

Published: March 27, 2023

This cross-sectional survey explored the attitudes and reasons, as well their associated factors, for receiving second booster dose of COVID-19 vaccine among a sample all old adults people with chronic medical conditions attending two randomly selected immunization centers in Naples (Italy). A total 438 questionnaires were collected. The majority male (55.1%) median age was 71 years. higher perception vaccine's utility, measured 10-point Likert type scale, has been observed males, individuals that is severe illness, self-awareness being at risk infection, trust information received. most reported reasons included protection themselves family members from getting COVID-19, fear acquiring disease, having physician's recommendation. Younger participants, married/cohabitant, illness more likely to have indicated protecting reason dose. Respondents condition, lower received, informed by physicians received because they perceived form SARS-CoV-2 infection. Physicians should play pivotal role stressing importance helping make decisions.

Language: Английский

A systematic literature review to clarify the concept of vaccine hesitancy DOI Open Access
Daphne Bussink-Voorend, Jeannine L.A. Hautvast, Lisa Vandeberg

et al.

Nature Human Behaviour, Journal Year: 2022, Volume and Issue: 6(12), P. 1634 - 1648

Published: Aug. 22, 2022

Language: Английский

Citations

141
Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy DOI Creative Commons
Lucio Folcarelli, Grazia Miraglia del Giudice, Francesco Corea

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(2), P. 146 - 146

Published: Jan. 19, 2022

This cross-sectional study, conducted in Naples (Italy) between 16 November and 6 December 2021, explored the willingness to receive booster dose of COVID-19 vaccine among a random sample selected from list those who had completed primary vaccination series at immunization center teaching hospital associated factors. Females significantly higher perceived risk getting SARS-CoV-2 infection, whereas not-having cohabitant were less worried. 85.7% willing dose. Those older respondents better health status after series, have friends/family members diagnosed with COVID-19, received information official government organizations, did not need would be get 24.7% was hesitant Vaccine Hesitancy Scale (VHS) score ≥ 25. Respondents self-rated lower needed hesitant. Information communication regarding benefits efficacy are order control pandemic.

Language: Английский

Citations

84
Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study DOI Creative Commons
Walid Al‐Qerem, Abdel Qader Al Bawab, Alaa M. Hammad

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(3), P. 410 - 410

Published: March 9, 2022

SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough infections increases. This is a cross-sectional study based on an online questionnaire Jordanian adults (n = 915) to determine how individuals who have finished current vaccination regimen feel about prospective booster shot what factors might influence their decision. Almost half participants (44.6%) intended get dose vaccine. The most frequently mentioned reasons participants' reluctance vaccine were "The benefits not been scientifically proven" (39.8%), followed by "I took last short time ago, there will be no need take at least year" (24.6%). In turn, was infected with COVID-19; thus, I do require dose" reported reason (13.1%). These findings highlight considerable hesitancy immunization among Jordanians, well variables associated hesitancy, which aid creating excellent campaigns regarding doses.

Language: Английский

Citations

72
COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study DOI Creative Commons
Mohamed Lounis, Djihad Bencherit, Mohammed Amir Rais

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(4), P. 621 - 621

Published: April 15, 2022

Due to the emergence of various highly contagious variants SARS-CoV-2, vaccine boosters were adopted as a complementary strategy in different countries. This has, however, posed another challenge for national authorities convince their population receive booster after first COVID-19 primer dose vaccines. study was conducted determine acceptance and its associated factors general Algeria. Using social media platforms, an online self-administered questionnaire distributed between 28 January 5 March 2022 all Algerian citizens who received Overall, 787 respondents included this study. Among them, 51.6%, 25%, 23.8% accepted, rejected, or hesitant about booster, respectively. However, only 13.2% declared receiving dose. Additionally, while 58.2% being relieved vaccination, 11.4% among them that they regretted vaccinated. The most common reasons experts' recommendations (24.6%) belief necessary efficient, rejection mainly due doses are sufficient (15.5%), vaccination is inefficient (8%). Males, older individuals, those with chronic comorbidities history infection, non-healthcare workers, low educational levels significantly higher odds acceptance. Moreover, disagreeing notion not sufficient, recommendations, desire travel abroad

Language: Английский

Citations

70
Determinants of COVID-19 vaccine fatigue DOI Creative Commons
Tanja Stamm, Julia Partheymüller, Erika Mosor

et al.

Nature Medicine, Journal Year: 2023, Volume and Issue: 29(5), P. 1164 - 1171

Published: March 27, 2023

There is growing concern that Coronavirus Disease 2019 (COVID-19) vaccine fatigue will be a major obstacle in maintaining immunity the general population. In this study, we assessed acceptance future scenarios two conjoint experiments, investigating determinants such as new vaccines, communication, costs/incentives and legal rules. The experiments were embedded an online survey (n = 6,357 participants) conducted European countries (Austria Italy). Our results suggest vaccination campaigns should tailored to subgroups based on their status. Among unvaccinated, campaign messages conveying community spirit had positive effect (0.343, confidence interval (CI) 0.019-0.666), whereas offering incentives, cash reward (0.722, CI 0.429-1.014) or voucher (0.670, 0.373-0.967), was pivotal decision-making of those vaccinated once twice. triple vaccinated, readiness increased when adapted vaccines offered (0.279, 0.182-0.377), but costs (-0.795, -0.935 -0.654) medical dissensus (-0.161, -0.293 -0.030) reduced likelihood get vaccinated. We conclude failing mobilize likely result booster rates falling short expectations. For long-term success, measures fostering institutional trust considered. These provide guidance responsible for COVID-19 campaigns.

Language: Английский

Citations

55
Acceptance of a Third Dose of COVID-19 Vaccine and Associated Factors in China Based on Health Belief Model: A National Cross-Sectional Study DOI Creative Commons
Chenyuan Qin,

Ruitong Wang,

Liyuan Tao

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(1), P. 89 - 89

Published: Jan. 7, 2022

COVID-19 infections are returning to many countries because of the emergence variants or declining antibody levels provided by vaccines. An additional dose vaccination is recommended be a considerable supplementary intervention. We aim explore public acceptance third vaccine and related influencing factors in China. This nationwide cross-sectional study was conducted general population among 31 provinces November, 2021. collected information on basic characteristics, knowledge attitudes, vaccine-related health beliefs participants. Univariable multivariable logistic regression models were used assess associated with vaccine. A total 93.7% (95% CI: 92.9-94.6%) 3119 Chinese residents willing receive Individuals low level perceived susceptibility, benefit, cues action cues, high barriers, old age, educational level, monthly household income, score less likely have (all p < 0.05). In model, mainly previous history [Sinopharm BBIP (aOR = 6.55, 95% CI 3.30-12.98), Sinovac 5.22, CI:2.72-10.02), Convidecia 5.80, 2.04-16.48)], susceptibility 2.48, 1.48-4.31) 23.66, 9.97-56.23). Overall, China showed willingness accept vaccines, which can help manufacturers manage production distribution for huge domestic international demand. Relevant institutions could increase people's booster shots increasing initial rates, public's perception through various strategies channels. Meanwhile, it also has certain reference significance other formulate promotion strategies.

Language: Английский

Citations

68
COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis DOI Creative Commons
Shaimaa Abdelaziz Abdelmoneim, Malik Sallam, Dina Mohamed Hafez

et al.

Tropical Medicine and Infectious Disease, Journal Year: 2022, Volume and Issue: 7(10), P. 298 - 298

Published: Oct. 13, 2022

The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary series for individuals ≥18 years and most-at-risk populations. This study aimed to estimate pooled proportion of COVID-19 vaccine uptake intention get among general populations healthcare workers (HCWs). We searched PsycINFO, Scopus, EBSCO, MEDLINE Central/PubMed, ProQuest, SciELO, SAGE, Web Science, Google Scholar, ScienceDirect according PRISMA guidelines. From a total 1079 screened records, 50 studies were extracted. Meta-analysis was conducted using 48 high-quality Newcastle-Ottawa Scale quality assessment tool. Using included studies, acceptance 198,831 subjects 81% (95% confidence interval (CI): 75–85%, I2 = 100%). actual in eight involving 12,995 31% CI: 19–46%, 100%), while have 79% 72–85%, vaccines HCWs 66% 58–74%), 99%). Meta-regression revealed that previous infection associated with lower dose. Conversely, significantly higher level uptake. WHO region Americas, which did not include any vaccination, 77% 66–85%, Western Pacific 89% 84–92%, 100), followed by European region: 86% 81–90%, 99%), Eastern Mediterranean 59% 46–71%, Southeast Asian 52% 43–61%, 95). Having chronic trust effectiveness significant predictors acceptance. global rate is high, but rates vary region. To achieve herd immunity disease, high required. Intensive campaigns programs are still needed around world raise public awareness regarding importance accepting proper control pandemic.

Language: Английский

Citations

64
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey DOI Creative Commons
Makoto Yoshida, Yurie Kobashi, Takeshi Kawamura

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(4), P. 515 - 515

Published: March 26, 2022

This was a retrospective cohort study, which aimed to investigate the factors associated with hesitancy receive third dose of coronavirus disease 2019 (COVID-19) vaccine. A paper-based questionnaire survey administered all participants. study included participants who provided answers in about whether they had an intent Data on sex, age, area residence, adverse reactions after second vaccination, vaccination desired, and reasons accept or hesitate over booster were retrieved. Among 2439 participants, mean (±SD) age 52.6 ± 18.9 years, median IgG-S antibody titer 324.9 (AU/mL), 97.9% indicated their dose. The logistic regression revealed that younger (OR = 0.98; 95% CI: 0.96-1.00) higher level 2.52; 1.27-4.99) positively efficacy COVID-19 vaccine concerns significant impact behavior regarding vaccination. rapid increase rate is needed control pandemic, specific approaches should be taken these groups are likely vaccine, subsequently increasing contact rate.

Language: Английский

Citations

63
Acceptance of COVID‐19 booster vaccination based on the protection motivation theory: A cross‐sectional study in China DOI
Fan Wu, Yue Yuan,

Zhaomin Deng

et al.

Journal of Medical Virology, Journal Year: 2022, Volume and Issue: 94(9), P. 4115 - 4124

Published: May 4, 2022

Abstract The promotion of the booster shots against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is an open issue to be discussed. Little known about public intention and influencing factors regarding vaccine. A cross‐sectional survey in Chinese adults was conducted using online questionnaire, which designed on basis protection motivation theory (PMT) scale vaccine hesitancy (VHS). Hierarchical multiple regression used compare fitness PMT VHS for predicting vaccination intention. Multivariable logistic analyze associated with acceptance. Six thousand three hundred twenty‐one (76.8%) participants were willing take shot. However, rest (23.2%) still hesitant more powerful than explaining Participants high perceived severity (adjusted odds ratio [aOR] = 0.69) response cost (aOR 0.47) less shots, but susceptibility 1.19), efficacy 2.13), self‐efficacy 3.33) shots. In summary, interventions based can provide guidance ensure acceptance

Language: Английский

Citations

60
Monkeypox Knowledge and Vaccine Hesitancy of Czech Healthcare Workers: A Health Belief Model (HBM)-Based Study DOI Creative Commons
Abanoub Riad, Anton Drobov,

Jana Rozmarinová

et al.

Vaccines, Journal Year: 2022, Volume and Issue: 10(12), P. 2022 - 2022

Published: Nov. 26, 2022

The recent human monkeypox virus (HMPXV) outbreak in non-endemic countries that started May 2022 has raised concerns among public health authorities worldwide. Healthcare workers (HCWs) play a decisive role during epidemics transmitting accurate information to the and motivating them pursue protective behaviours, including immunisation.

Language: Английский

Citations

58